ALBEMARLE CORP (ALB) Insider Transactions

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares withheld to meet tax liabilities associated with vesting of RSUs.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 The transaction represents dividends acquired under an automatic dividend reinvestment program for Company stock.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Restricted Stock Units that vest 100% on 03/14/2028, subject to the terms of the award agreement.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Restricted Stock Units that vest 100% on 03/14/2028, subject to the terms of the award agreement.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Restricted Stock Units that vest 50% on 03/14/2028 and 50% on 09/14/2029, subject to the terms of the award agreement.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Restricted Stock Units that vest in three equal increments on each of the first, second, and third anniversary of the grant date, subject to the terms of the award agreement.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares represent a pro rata grant of an annual installment of non-employee director stock compensation to those directors who become directors after the first day of the Compensation Year pursuant to the Albemarle Corporation 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors. Shares to vest on July 1, 2027.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2027.

F2 Represents dividends accrued on shares underlying an award granted on February 26, 2026, that vested in full on July 1, 2026, which the Issuer elected to settle in shares of common stock under the 2023 Directors Plan.

References: F2

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2027.

F2 Represents dividends accrued on shares underlying an award granted on February 26, 2026, that vested in full on July 1, 2026, which the Issuer elected to settle in shares of common stock under the 2023 Directors Plan.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares represent an annual award of non-employee director stock compensation issued under the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2027.

F2 Shares reported were withheld to meet tax liabilities associated with vesting of a grant originally made on July 1, 2025.

F3 Represents dividends accrued on shares underlying an award granted on July 1, 2025, that vested in full on July 1, 2026, which the Issuer elected to settle in shares of common stock issued under the 2023 Directors Plan.

F4 Shares reported were withheld to meet tax liabilities associated with vesting of dividends accrued on a grant originally made on July 1, 2025.

References: F4

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares represent an annual award of non-employee director stock compensation issued under the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2027.

F2 Shares reported were withheld to meet tax liabilities associated with vesting of a grant originally made on July 1, 2025.

F3 Represents dividends accrued on shares underlying an award granted on July 1, 2025, that vested in full on July 1, 2026, which the Issuer elected to settle in shares of common stock issued under the 2023 Directors Plan.

F4 Shares reported were withheld to meet tax liabilities associated with vesting of dividends accrued on a grant originally made on July 1, 2025.

References: F3

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares represent an annual award of non-employee director stock compensation issued under the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2027.

F2 Shares reported were withheld to meet tax liabilities associated with vesting of a grant originally made on July 1, 2025.

F3 Represents dividends accrued on shares underlying an award granted on July 1, 2025, that vested in full on July 1, 2026, which the Issuer elected to settle in shares of common stock issued under the 2023 Directors Plan.

F4 Shares reported were withheld to meet tax liabilities associated with vesting of dividends accrued on a grant originally made on July 1, 2025.

References: F2

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares represent an annual award of non-employee director stock compensation issued under the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2027.

F2 Shares reported were withheld to meet tax liabilities associated with vesting of a grant originally made on July 1, 2025.

F3 Represents dividends accrued on shares underlying an award granted on July 1, 2025, that vested in full on July 1, 2026, which the Issuer elected to settle in shares of common stock issued under the 2023 Directors Plan.

F4 Shares reported were withheld to meet tax liabilities associated with vesting of dividends accrued on a grant originally made on July 1, 2025.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2027.

F2 Holdings have been adjusted to reflect a transfer of 893 shares of Common Stock pursuant to an agreement of separation of assets entered into by the Reporting Person.

F3 Represents dividends accrued on shares underlying an award granted on July 1, 2025, that vested in full on July 1, 2026, which the Issuer elected to settle in shares of common stock issued under the 2023 Directors Plan.

References: F3

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2027.

F2 Holdings have been adjusted to reflect a transfer of 893 shares of Common Stock pursuant to an agreement of separation of assets entered into by the Reporting Person.

F3 Represents dividends accrued on shares underlying an award granted on July 1, 2025, that vested in full on July 1, 2026, which the Issuer elected to settle in shares of common stock issued under the 2023 Directors Plan.

References: F1, F2

Reported filing row; may be amended. Do not sum filings blindly.

F1 The transaction represents dividends acquired under an automatic dividend reinvestment program for Company stock.

F2 Phantom Stock units convert 1 for 1 into common stock.

F3 Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Directors Plan. Shares to vest on July 1, 2027.

F4 Payable as shares of common stock upon events established by the reporting person in accordance with the terms of the 2023 Directors Plan.

F5 No expiration date.

F6 Includes dividend equivalent rights earned based on total Phantom Stock units in Director's deferred stock account.

References: F2, F3, F4, F5, F6

Reported filing row; may be amended. Do not sum filings blindly.

F1 The transaction represents dividends acquired under an automatic dividend reinvestment program for Company stock.

F2 Phantom Stock units convert 1 for 1 into common stock.

F3 Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Directors Plan. Shares to vest on July 1, 2027.

F4 Payable as shares of common stock upon events established by the reporting person in accordance with the terms of the 2023 Directors Plan.

F5 No expiration date.

F6 Includes dividend equivalent rights earned based on total Phantom Stock units in Director's deferred stock account.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Phantom Stock units convert 1 for 1 into common stock.

F2 Phantom Stock units represent an annual award of non-employee director stock compensation issued under the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Units to vest on July 1, 2027.

F3 Payable as shares of common stock upon events established by the reporting person in accordance with the terms of the 2023 Directors Plan.

F4 No expiration date.

F5 Includes dividend equivalent rights earned based on total shares of Phantom Stock in reporting person's deferred stock account.

References: F1, F2, F3, F4, F5

Reported filing row; may be amended. Do not sum filings blindly.

F1 Phantom Stock units convert 1 for 1 into common stock.

F2 Phantom Stock units represent an annual award of non-employee director stock compensation issued under the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Units to vest on July 1, 2027.

F3 Payable as shares of common stock upon events established by the reporting person in accordance with the terms of the 2023 Directors Plan.

F4 No expiration date.

F5 Includes dividend equivalent rights earned based on total shares of Phantom Stock in reporting person's deferred stock account.

References: F1, F2, F3, F4, F5

Reported filing row; may be amended. Do not sum filings blindly.

F1 Phantom Stock units convert 1 for 1 into common stock.

F2 Phantom Stock units represent an annual award of non-employee director stock compensation issued under the 2023 Directors Plan. Units to vest on July 1, 2027.

F3 Payable as shares of common stock upon events established by the reporting person in accordance with the terms of the 2023 Directors Plan.

F4 No expiration date.

F5 Includes dividend equivalent rights earned based on total Phantom Stock units in Director's deferred stock account.

References: F1, F2, F3, F4, F5

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2027.

F2 Represents dividends accrued on shares underlying an award granted on July 1, 2025, that vested in full on July 1, 2026, which the Issuer elected to settle in shares of common stock under the 2023 Directors Plan.

References: F2

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2027.

F2 Represents dividends accrued on shares underlying an award granted on July 1, 2025, that vested in full on July 1, 2026, which the Issuer elected to settle in shares of common stock under the 2023 Directors Plan.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2027.

F2 Represents dividends accrued on shares underlying an award granted on July 1, 2025, that vested in full on July 1, 2026, which the Issuer elected to settle in shares of common stock under the 2023 Directors Plan.

References: F2

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2027.

F2 Represents dividends accrued on shares underlying an award granted on July 1, 2025, that vested in full on July 1, 2026, which the Issuer elected to settle in shares of common stock under the 2023 Directors Plan.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person for diversification and tax planning purposes in multiple transactions, at prices ranging from $182.415 to $183.41, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person for diversification and tax planning purposes in multiple transactions, at prices ranging from $183.42 to $184.40, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person for diversification and tax planning purposes in multiple transactions, at prices ranging from $184.43 to $184.54, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reporting person retains significant holdings in Albemarle stock, in excess of his required holdings under Albemarle stock ownership guidelines.

References: F3